
News|Articles|May 4, 2004
Enoxaparin clinically equivalent to UFH in the treatment of high-risk ACS
>Enoxaparin is an effective and safe alternative to unfractionated heparin (UFH) in the early and invasive management of high-risk patients with non-ST-elevation acute coronary syndromes (ACS), said Robert Califf, MD, at the 53rd Annual Scientific Session of the American College of Cardiology (ACC).
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Patients may not see savings from new Medicare drug programs
2
Sanofi acquires Dynavax for $2.2 billion to bolster vaccine portfolio
3
FDA accepts NDA for gedatolisib, Celcuity’s investigational breast cancer treatment
4
Why Timing, Access and Interpretation Matter in Oncology Biomarker Testing
5




















































